CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.280
  • +0.040+1.79%
15min DelayMarket Closed Nov 19 16:00 ET
160.30MMarket Cap-6000P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-302.52%-5.75M
-109.18%-4.18M
32.09%-3.25M
36.49%-11.3M
38.93%-3.09M
70.28%-1.43M
45.90%-2M
-13.11%-4.78M
-115.07%-17.78M
-76.92%-5.05M
Net income from continuing operations
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Operating gains losses
-263.26%-1.67M
1,201.29%1.86M
-1,483.48%-2.27M
297.34%5.12M
628.50%3.79M
153.44%1.02M
285.75%142.6K
4,273.79%164.03K
-8,172.95%-2.6M
-1,480.34%-718.02K
Depreciation and amortization
-60.00%14.65K
-57.06%15.03K
10.22%38.31K
25.96%145K
11.13%38.62K
5.39%36.63K
2.27%35K
205.29%34.75K
170.06%115.11K
210.14%34.75K
Remuneration paid in stock
-7.57%1.62M
-37.49%1.35M
56.28%1.15M
117.83%6.04M
159.18%1.39M
187.55%1.75M
160.24%2.16M
-7.57%736.78K
-30.90%2.77M
-50.10%537.12K
Other non cashItems
-99.97%1
81.35%6.94K
-31.37%2.85K
-97.23%14.66K
-28.72%3.18K
-99.32%3.51K
--3.83K
--4.15K
--528.9K
--4.46K
Change In working capital
-936.03%-495.15K
-0.84%415.56K
117.27%174.85K
-111.36%-240.35K
-71.45%293.54K
110.47%59.23K
-75.59%419.1K
-1,473.59%-1.01M
391.28%2.11M
581.31%1.03M
-Change in receivables
-69.54%5.11K
-95.95%2.03K
474.63%236.63K
-703.60%-223.18K
-43,531.54%-226.88K
-76.13%16.78K
285.95%50.08K
-975.86%-63.16K
2,726.07%36.98K
97.64%-520
-Change in prepaid assets
-3.29%-164.92K
136.12%121.77K
-145.94%-170.85K
123.65%57.32K
166.31%182.21K
-407.73%-159.67K
-519.63%-337.15K
472.82%371.94K
-314.12%-242.33K
-259.54%-274.8K
-Change in payables and accrued expense
-265.92%-335.34K
-58.68%291.77K
108.26%109.07K
-103.21%-74.49K
-74.05%338.21K
129.39%202.12K
-57.54%706.17K
-3,297.88%-1.32M
627.98%2.32M
186,121.57%1.3M
Cash from discontinued investing activities
Operating cash flow
-302.52%-5.75M
-109.18%-4.18M
32.09%-3.25M
36.49%-11.3M
38.93%-3.09M
70.28%-1.43M
45.90%-2M
-13.11%-4.78M
-115.07%-17.78M
-76.92%-5.05M
Investing cash flow
Cash flow from continuing investing activities
118.22%25.23K
385.70%8.41K
0
-557.92%-138.85K
1
-2,320.19%-138.46K
70.54%-2.94K
147.27%2.55K
53.19%-21.11K
0
Net PPE purchase and sale
--0
--0
--0
85.43%-3.07K
--1
53.17%-2.68K
70.54%-2.94K
147.27%2.55K
-667.73%-21.11K
--0
Net intangibles purchas and sale
--25.23K
----
----
---135.78K
--0
----
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
118.22%25.23K
385.70%8.41K
--0
-557.92%-138.85K
--1
-2,320.19%-138.46K
70.54%-2.94K
147.27%2.55K
53.19%-21.11K
--0
Financing cash flow
Cash flow from continuing financing activities
272.66%269.74K
-56.17%111.28K
5,924.01%22M
-96.62%766.29K
-6.16%74.77K
-99.64%72.38K
-90.09%253.86K
184.63%365.27K
15.44%22.64M
-99.31%79.68K
Net issuance payments of debt
0.00%-25.23K
0.00%-25.23K
0.00%-25.23K
-33.33%-100.93K
0.00%-25.23K
-0.00%-25.23K
0.00%-25.23K
---25.23K
---75.7K
---25.23K
Net common stock issuance
--0
--0
--23.01M
--0
--0
--0
--0
--0
4.56%19.76M
-99.06%108.35K
Proceeds from stock option exercised by employees
202.16%294.95K
-41.26%163.95K
58.89%620.46K
-71.87%867.21K
-20.38%100K
-58.51%97.61K
-89.24%279.09K
204.29%390.51K
29.67%3.08M
-87.89%125.6K
Net other financing activities
--19
---27.44K
---1.6M
----
----
----
----
----
92.26%-129.04K
----
Cash from discontinued financing activities
Financing cash flow
272.66%269.74K
-56.17%111.28K
5,924.01%22M
-96.62%766.29K
-6.16%74.77K
-99.64%72.38K
-90.09%253.86K
184.63%365.27K
15.44%22.64M
-99.31%79.68K
Net cash flow
Beginning cash position
65.15%26.56M
68.15%30.3M
-48.07%11.66M
32.62%22.45M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
202.38%16.93M
235.78%27.7M
Current changes in cash
-265.01%-5.46M
-132.37%-4.06M
524.97%18.76M
-320.59%-10.67M
39.46%-3.01M
-109.93%-1.5M
-53.06%-1.75M
-7.54%-4.41M
-57.20%4.84M
-156.97%-4.97M
Effect of exchange rate changes
-147.23%-93.56K
266.02%317.11K
-585.85%-112.37K
-118.04%-123.89K
58.18%-114.58K
-80.06%198.07K
-416.69%-191K
-516.90%-16.38K
2,088.15%686.58K
-426.66%-273.95K
End cash Position
42.09%21.01M
65.15%26.56M
68.15%30.3M
-48.07%11.66M
-48.07%11.66M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
32.62%22.45M
Free cash from
-266.97%-5.75M
-108.88%-4.18M
32.09%-3.25M
35.77%-11.44M
38.93%-3.09M
67.44%-1.57M
45.97%-2M
-12.97%-4.78M
-114.15%-17.81M
-76.92%-5.05M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -302.52%-5.75M-109.18%-4.18M32.09%-3.25M36.49%-11.3M38.93%-3.09M70.28%-1.43M45.90%-2M-13.11%-4.78M-115.07%-17.78M-76.92%-5.05M
Net income from continuing operations -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Operating gains losses -263.26%-1.67M1,201.29%1.86M-1,483.48%-2.27M297.34%5.12M628.50%3.79M153.44%1.02M285.75%142.6K4,273.79%164.03K-8,172.95%-2.6M-1,480.34%-718.02K
Depreciation and amortization -60.00%14.65K-57.06%15.03K10.22%38.31K25.96%145K11.13%38.62K5.39%36.63K2.27%35K205.29%34.75K170.06%115.11K210.14%34.75K
Remuneration paid in stock -7.57%1.62M-37.49%1.35M56.28%1.15M117.83%6.04M159.18%1.39M187.55%1.75M160.24%2.16M-7.57%736.78K-30.90%2.77M-50.10%537.12K
Other non cashItems -99.97%181.35%6.94K-31.37%2.85K-97.23%14.66K-28.72%3.18K-99.32%3.51K--3.83K--4.15K--528.9K--4.46K
Change In working capital -936.03%-495.15K-0.84%415.56K117.27%174.85K-111.36%-240.35K-71.45%293.54K110.47%59.23K-75.59%419.1K-1,473.59%-1.01M391.28%2.11M581.31%1.03M
-Change in receivables -69.54%5.11K-95.95%2.03K474.63%236.63K-703.60%-223.18K-43,531.54%-226.88K-76.13%16.78K285.95%50.08K-975.86%-63.16K2,726.07%36.98K97.64%-520
-Change in prepaid assets -3.29%-164.92K136.12%121.77K-145.94%-170.85K123.65%57.32K166.31%182.21K-407.73%-159.67K-519.63%-337.15K472.82%371.94K-314.12%-242.33K-259.54%-274.8K
-Change in payables and accrued expense -265.92%-335.34K-58.68%291.77K108.26%109.07K-103.21%-74.49K-74.05%338.21K129.39%202.12K-57.54%706.17K-3,297.88%-1.32M627.98%2.32M186,121.57%1.3M
Cash from discontinued investing activities
Operating cash flow -302.52%-5.75M-109.18%-4.18M32.09%-3.25M36.49%-11.3M38.93%-3.09M70.28%-1.43M45.90%-2M-13.11%-4.78M-115.07%-17.78M-76.92%-5.05M
Investing cash flow
Cash flow from continuing investing activities 118.22%25.23K385.70%8.41K0-557.92%-138.85K1-2,320.19%-138.46K70.54%-2.94K147.27%2.55K53.19%-21.11K0
Net PPE purchase and sale --0--0--085.43%-3.07K--153.17%-2.68K70.54%-2.94K147.27%2.55K-667.73%-21.11K--0
Net intangibles purchas and sale --25.23K-----------135.78K--0--------------0--0
Cash from discontinued investing activities
Investing cash flow 118.22%25.23K385.70%8.41K--0-557.92%-138.85K--1-2,320.19%-138.46K70.54%-2.94K147.27%2.55K53.19%-21.11K--0
Financing cash flow
Cash flow from continuing financing activities 272.66%269.74K-56.17%111.28K5,924.01%22M-96.62%766.29K-6.16%74.77K-99.64%72.38K-90.09%253.86K184.63%365.27K15.44%22.64M-99.31%79.68K
Net issuance payments of debt 0.00%-25.23K0.00%-25.23K0.00%-25.23K-33.33%-100.93K0.00%-25.23K-0.00%-25.23K0.00%-25.23K---25.23K---75.7K---25.23K
Net common stock issuance --0--0--23.01M--0--0--0--0--04.56%19.76M-99.06%108.35K
Proceeds from stock option exercised by employees 202.16%294.95K-41.26%163.95K58.89%620.46K-71.87%867.21K-20.38%100K-58.51%97.61K-89.24%279.09K204.29%390.51K29.67%3.08M-87.89%125.6K
Net other financing activities --19---27.44K---1.6M--------------------92.26%-129.04K----
Cash from discontinued financing activities
Financing cash flow 272.66%269.74K-56.17%111.28K5,924.01%22M-96.62%766.29K-6.16%74.77K-99.64%72.38K-90.09%253.86K184.63%365.27K15.44%22.64M-99.31%79.68K
Net cash flow
Beginning cash position 65.15%26.56M68.15%30.3M-48.07%11.66M32.62%22.45M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M202.38%16.93M235.78%27.7M
Current changes in cash -265.01%-5.46M-132.37%-4.06M524.97%18.76M-320.59%-10.67M39.46%-3.01M-109.93%-1.5M-53.06%-1.75M-7.54%-4.41M-57.20%4.84M-156.97%-4.97M
Effect of exchange rate changes -147.23%-93.56K266.02%317.11K-585.85%-112.37K-118.04%-123.89K58.18%-114.58K-80.06%198.07K-416.69%-191K-516.90%-16.38K2,088.15%686.58K-426.66%-273.95K
End cash Position 42.09%21.01M65.15%26.56M68.15%30.3M-48.07%11.66M-48.07%11.66M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M32.62%22.45M
Free cash from -266.97%-5.75M-108.88%-4.18M32.09%-3.25M35.77%-11.44M38.93%-3.09M67.44%-1.57M45.97%-2M-12.97%-4.78M-114.15%-17.81M-76.92%-5.05M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data